The global medical imaging workstations market is projected to grow from USD 9.96 billion in 2025 to USD 16.73 billion by 2034, at a CAGR of 5.93%. Growth is fueled by advancements in imaging technologies (MRI, CT, ultrasound, 3D imaging), rising cases of chronic diseases, an aging population, and increasing adoption of AI and telemedicine in diagnostics.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Medical Imaging Workstations Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Medical Imaging Workstations Market, by Usage Mode
8.1.1. Thick Client Workstations
8.1.1.1. Market Revenue and Forecast
8.1.2. Thin Client Workstations
8.1.2.1. Market Revenue and Forecast
9.1. Medical Imaging Workstations Market, by Application
9.1.1. Conventional Imaging
9.1.1.1. Market Revenue and Forecast
9.1.2. Advanced Imaging
9.1.2.1. Market Revenue and Forecast
10.1. Medical Imaging Workstations Market, by Component
10.1.1. Visualization Software
10.1.1.1. Market Revenue and Forecast
10.1.2. Hardware
10.1.2.1. Market Revenue and Forecast
11.1. Medical Imaging Workstations Market, by Modality
11.1.1. Computed Tomography (CT)
11.1.1.1. Market Revenue and Forecast
11.1.2. Magnetic Resonance Imaging (MRI)
11.1.2.1. Market Revenue and Forecast
11.1.3. Ultrasound
11.1.3.1. Market Revenue and Forecast
11.1.4. Mammography
11.1.4.1. Market Revenue and Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Usage Mode
12.1.2. Market Revenue and Forecast, by Application
12.1.3. Market Revenue and Forecast, by Component
12.1.4. Market Revenue and Forecast, by Modality
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Usage Mode
12.1.5.2. Market Revenue and Forecast, by Application
12.1.5.3. Market Revenue and Forecast, by Component
12.1.5.4. Market Revenue and Forecast, by Modality
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Usage Mode
12.1.6.2. Market Revenue and Forecast, by Application
12.1.6.3. Market Revenue and Forecast, by Component
12.1.6.4. Market Revenue and Forecast, by Modality
12.2. Europe
12.2.1. Market Revenue and Forecast, by Usage Mode
12.2.2. Market Revenue and Forecast, by Application
12.2.3. Market Revenue and Forecast, by Component
12.2.4. Market Revenue and Forecast, by Modality
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Usage Mode
12.2.5.2. Market Revenue and Forecast, by Application
12.2.5.3. Market Revenue and Forecast, by Component
12.2.5.4. Market Revenue and Forecast, by Modality
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Usage Mode
12.2.6.2. Market Revenue and Forecast, by Application
12.2.6.3. Market Revenue and Forecast, by Component
12.2.6.4. Market Revenue and Forecast, by Modality
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Usage Mode
12.2.7.2. Market Revenue and Forecast, by Application
12.2.7.3. Market Revenue and Forecast, by Component
12.2.7.4. Market Revenue and Forecast, by Modality
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Usage Mode
12.2.8.2. Market Revenue and Forecast, by Application
12.2.8.3. Market Revenue and Forecast, by Component
12.2.8.4. Market Revenue and Forecast, by Modality
12.3. APAC
12.3.1. Market Revenue and Forecast, by Usage Mode
12.3.2. Market Revenue and Forecast, by Application
12.3.3. Market Revenue and Forecast, by Component
12.3.4. Market Revenue and Forecast, by Modality
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Usage Mode
12.3.5.2. Market Revenue and Forecast, by Application
12.3.5.3. Market Revenue and Forecast, by Component
12.3.5.4. Market Revenue and Forecast, by Modality
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Usage Mode
12.3.6.2. Market Revenue and Forecast, by Application
12.3.6.3. Market Revenue and Forecast, by Component
12.3.6.4. Market Revenue and Forecast, by Modality
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Usage Mode
12.3.7.2. Market Revenue and Forecast, by Application
12.3.7.3. Market Revenue and Forecast, by Component
12.3.7.4. Market Revenue and Forecast, by Modality
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Usage Mode
12.3.8.2. Market Revenue and Forecast, by Application
12.3.8.3. Market Revenue and Forecast, by Component
12.3.8.4. Market Revenue and Forecast, by Modality
12.4. MEA
12.4.1. Market Revenue and Forecast, by Usage Mode
12.4.2. Market Revenue and Forecast, by Application
12.4.3. Market Revenue and Forecast, by Component
12.4.4. Market Revenue and Forecast, by Modality
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Usage Mode
12.4.5.2. Market Revenue and Forecast, by Application
12.4.5.3. Market Revenue and Forecast, by Component
12.4.5.4. Market Revenue and Forecast, by Modality
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Usage Mode
12.4.6.2. Market Revenue and Forecast, by Application
12.4.6.3. Market Revenue and Forecast, by Component
12.4.6.4. Market Revenue and Forecast, by Modality
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Usage Mode
12.4.7.2. Market Revenue and Forecast, by Application
12.4.7.3. Market Revenue and Forecast, by Component
12.4.7.4. Market Revenue and Forecast, by Modality
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Usage Mode
12.4.8.2. Market Revenue and Forecast, by Application
12.4.8.3. Market Revenue and Forecast, by Component
12.4.8.4. Market Revenue and Forecast, by Modality
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Usage Mode
12.5.2. Market Revenue and Forecast, by Application
12.5.3. Market Revenue and Forecast, by Component
12.5.4. Market Revenue and Forecast, by Modality
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Usage Mode
12.5.5.2. Market Revenue and Forecast, by Application
12.5.5.3. Market Revenue and Forecast, by Component
12.5.5.4. Market Revenue and Forecast, by Modality
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Usage Mode
12.5.6.2. Market Revenue and Forecast, by Application
12.5.6.3. Market Revenue and Forecast, by Component
12.5.6.4. Market Revenue and Forecast, by Modality
13.1. Accuray Incorporated
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. CANON MEDICAL SYSTEMS CORPORATION
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Carestream Health
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. CARL ZEISS MEDITEC AG
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. FUJIFILM Holdings Corporation
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. GE HealthCare
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Koninklijke Philips N.V.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. NGI Group
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Siemens Healthineers AG
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Report Description
Get a Sample
Report Description